Danaher Revenues Grow 24 Percent in Q2

The acquisitions of AB Sciex and Molecular Devices helped Danaher's Medical Technologies segment increase its revenues 31 percent during the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.